开幕式

09.00-09.30

会议1：肿瘤病毒的分子流行病学

09.30-11.30
致癌的传染病
Harald zur Hausen, Deutsches Krebsforschungszentrum, Heidelberg, Germany
EBV Strains and NPC Pathogenesis
Nancy Raab-Traub, University of North Carolina, Chapel Hill, NC, USA
Prevention of Hepatocellular Carcinoma by Immunization against Hepatitis B Virus Infection
Ding-Shinn Chen, National Taiwan University Hospital, Taipei, Taiwan
HPV and the Treatment of Squamous Cell Carcinoma of the Head and Neck
Everett E. Vokes, University of Chicago Medical Center, Chicago, IL, USA

会议2：跨学科治疗方法

11.50-12.40
肝癌的治疗
Sheung-tat Fan, The University of Hong Kong, Hong Kong SAR, China
Chemoradiation in NPC
Joseph Wee, Singapore General Hospital, Singapore

海报展 A

12.40-14.10

会议3： EPSTEIN BARR病毒诱发肿瘤的分子病理学

14.10-15.40
EBV 分子病理学
Elliott Kieff, Harvard University, Boston, MA, USA
EBV and Cancer: When Persistent Inspection Goes Bad
Lawrence S. Young, University of Birmingham, Birmingham, United Kingdom
Functional Role of EBV microRNAs
S. Diane Hayward, Johns Hopkins University, Baltimore, MD, USA

会议4： HEPATOCELLULAR CARCINOGENESIS

16.00-17.00
Factors Associated with the Development of HBV-related HCC
Ming-Whei Yu, National Taiwan University, Taipei, Taiwan
HCC Susceptibility Genes in Patients with Hepatitis C
Naoya Kato, University of Tokyo, Tokyo, Japan

招待会

17.15-18.15

会议5：干细胞与癌症

09.00-10.00
干细胞与胃癌
JeanMarie Houghton, University of Massachusetts, Worcester, MA, USA
肝细胞癌的干细胞
Snorri S. Thorgeirsson, NCI-CCR, Bethesda, MD, USA

会议6：化学预防

10.20-12.50
21世纪的化学预防：基因、风险模式和靶向化学预防
Waun Ki Hong, UT M. D. Anderson Cancer Center, Houston, TX, USA
HPV疫苗预防宫颈CA的功效
T. C. Wu, Johns Hopkins Medical Institutions, Baltimore, MD, USA
高风险HPV引起的已知疾病的免疫疗法
Cornelis J. M. Melief, University Hospital, Leiden, The Netherlands
HPV与人类癌症：机理
Peter M. Howley, Harvard Medical School, Boston, MA, USA
HBV/HCV 治疗能降低HCC风险吗？
Joseph J. Y. Sung, Chinese University of Hong Kong, Hong Kong SAR, China

海报展 B

12.50-14.15

会议7： 癌症筛查

14.15-15.45
胃癌癌前病变的发病机理：预防靶向
Naomi Uemura, Kure Kyosai Hospital, Kure, Japan
作为癌症筛检工具的血浆核酸
Y. M. Dennis Lo, Chinese University of Hong Kong, Hong Kong SAR, China
HCC筛检
Tony S. K. Mok, Chinese University of Hong Kong, Hong Kong SAR, China

会议8：幽门螺杆菌与胃癌的病理生理学
16.00-17.00
胃癌的主要病因和其他联合病因
Wai Keung Leung, Chinese University of Hong Kong, Hong Kong SAR, China
幽门螺杆菌与胃癌预防：希望与缺陷
Julie Parsonnet, Stanford University, Stanford, CA, USA

会议9：艾伯斯坦-巴尔病毒与鼻咽癌发病机理

09.00-10.00
EBV感染与NPC恶化
Yi-Xin Zeng, Sut Yat-Sen University of Medical Sciences, Guangzhou, China 
EBV调解鼻咽癌STAT 信号
Honglin Chen, University of Hong Kong, Hong Kong SAR, China

会议10： 基因与癌症的实验胚胎学

10.20-12.20
NP细胞转换的细胞和滤过性毒菌致癌基因
Musheng Zeng, Sun Yat-Sen University of Medical Sciences, Guangzhou, China
肝细胞癌的细胞基因和分子基因改变
Natalie Wong, Chinese University of Hong Kong, Hong Kong SAR, China
新抑癌基因的表观辨认
Qian Tao, Chinese University of Hong Kong, Hong Kong SAR, China
与EBV有关的天然杀伤恶性细胞的基因和表观改变
Gopesh Srivastava, Queen Mary Hospital, Hong Kong SAR, China

海报展 C

12.20-13.50

会议11： 肿瘤病毒的免疫疗法

13.50-14.50
生殖HPV感染的免疫疗法：基础和转换
Douglas R. Lowy, NCI-CCR, Bethesda, MD, USA
改进与EBV有关的恶性肿瘤的T细胞治疗
Cliona M. Rooney, The Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA

会议12：新疗法

15.10-16.40 
肝细胞癌和靶向治疗的分子生物学
Melanie B. Thomas, UT M. D. Anderson Cancer Center, Houston, TX, USA
作为成像和治疗策略的EBV和细胞溶解酶激活
Richard F. Ambinder, Johns Hopkins University, Baltimore, MD, USA
鼻咽癌的新系统疗法
Brigette B. Ma, Chinese University of Hong Kong, Hong Kong SAR, China

离开